Function and Therapeutic Potential of Non-Coding RNAs in Cardiac Fibrosis

Esther E Creemers, Eva van Rooij

Research output: Contribution to journal/periodicalArticleScientificpeer-review

79 Citations (Scopus)


Cardiac fibrosis as a result of excessive extracellular matrix deposition leads to stiffening of the heart, which can eventually lead to heart failure. An important event in cardiac fibrosis is the transformation of fibroblasts into myofibroblasts, which secrete large amounts of extracellular matrix proteins. While the function of protein-coding genes in myofibroblast activation and fibrosis has been a topic of investigation for a long time, it has become clear that non-coding RNAs also play key roles in cardiac fibrosis. This review discusses the involvement of microRNAs and lncRNAs in cardiac fibrosis and summarizes the issues related to translating these findings into real life therapies.

Original languageEnglish
JournalCirculation Research
Early online date04 Nov 2015
Publication statusPublished - 08 Jan 2016


Dive into the research topics of 'Function and Therapeutic Potential of Non-Coding RNAs in Cardiac Fibrosis'. Together they form a unique fingerprint.

Cite this